top glp 1 drug companies GLP-1 Drugs The Next Big Weight Loss
Description
2025 Jan 9;20(Suppl 6):e088069
10.1016/S1474-4422(20)30173-3 Lancet Neurol
However, in the matched cohort, a full 13,767 individuals had more than two years of follow-up time, with nearly half of those (n = 6,650) having more than four years
But beneath the hype and fear is a simple story: these drugs target a core metabolic signaling pathway that influences cardiovascular health, inflammation, cognition, kidney function, and long-term resilience
